Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows
医学
疾病
阿尔茨海默病
重症监护医学
内科学
作者
Rita Rubin
出处
期刊:JAMA [American Medical Association] 日期:2025-08-22
标识
DOI:10.1001/jama.2025.14180
摘要
This Medical News article discusses the safety and effectiveness of lecanemab and donanemab in treating mild cognitive impairment and early Alzheimer disease outside clinical trials.